Search clinical trials for: HSV encephalitis

Total 563 results

University Hospital, Strasbourg, France

Unknown

Interest Balance Auto-immune Population in Patients With Focal Epilepsy of Unknown Cause, Not Structural, Not Genetics, Newly Diagnosed (IBADEPIF)

Epilepsy

France
Assistance Publique Hopitaux De Marseille

Unknown

Etiology of Orphan Community-based Meningitis and Meningo-encephalitis. (MENINGITE)

Meningo-encephalitis | Community-based Meningitis

France
Centers for Disease Control and Prevention, China
Centers for Disease Control and Prevention; Zhejiang Provincial Center for... and other collaborators

Completed

Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines (MR+JE)

Japanese Encephalitis | Measles | Rubella

China
National Institute of Hygiene and Epidemiology,...
Ministry of Health, Vietnam; Ministry of Science and Technology, Vietnam

Completed

Safety and Immunogenicity of JECEVAX in Young Children

Japanese Encephalitis

Vietnam
University of Alabama at Birmingham

Withdrawn

A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease)

Herpes Simplex Virus

United States
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)

Terminated

Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery

Recurrent Childhood Anaplastic Astrocytoma | Recurrent Childhood Anaplastic Oligoastrocytoma | Recurrent Childhood Anaplastic Oligodendroglioma | Recurrent Childhood Giant Cell Glioblastoma | Recurrent Childhood Glioblastoma | Recurrent Childhood Gliomatosis Cerebri | Recurrent Childhood Gliosarcoma

United States
Valneva Austria GmbH

Completed

Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling

Japanese Encephalitis

Germany, Austria
Sanofi Pasteur, a Sanofi Company

Completed

Post-licensure Safety Study of IMOJEV® in Thailand

Japanese Encephalitis

Thailand
Beech Tree Labs, Inc.
Norwich Clinical Research Associates Ltd.; Hill Top Research

Completed

Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores

Oral Herpes Simplex

United States
Novartis Vaccines

Completed

Novartis Vaccine and Diagnostics Carriage Trial

N. Meningitidis Carriage

United Kingdom
Southern Illinois University

Withdrawn

Antiviral Prophylaxis in a Burn Population

Herpes Simplex

United States
Singapore General Hospital
Duke-NUS Graduate Medical School

Completed

The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans

Encephalitis, Japanese | Yellow Fever

Singapore
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults

West Nile Fever

United States
Charite University, Berlin, Germany

Completed

Transcranial Direct Current Stimulation on Cortical Plasticity in Patients With Anti-NMDA Receptor Encephalitis

Anti-NMDA Receptor Encephalitis

Germany
University of Pittsburgh
Eli Lilly and Company; Genentech, Inc.

Completed

Study of Pemetrexed and Bevacizumab in Patients With Head and Neck Cancer

Cancer

United States
Beth Israel Deaconess Medical Center
Biogen; National Multiple Sclerosis Society

Completed

JC Virus Reactivation in Multiple Sclerosis (JCV in MS)

Multiple Sclerosis | Progressive Multifocal Leukoencephalopathy

United States
Chulalongkorn University
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity of a JE-CV as a Booster Dose After a Primary Vaccination With SA14-14-2 Vaccine

Japanese Encephalitis
University of Michigan

Completed

Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric Lupus

Systemic Lupus Erythematosus | Fibromyalgia | Acute Neuropsychiatric Lupus

United States
University of Michigan

Completed

Magnetic Resonance Spectroscopy, Perfusion, and Diffusion Tensor Imaging in Neuropsychiatric Lupus

Neuropsychiatric Systemic Lupus Erythematosus

United States
Sormland County Council, Sweden

Completed

Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Tick-borne Encephalitis

Finland, Sweden
Beijing Tongren Hospital
Peking Union Medical College Hospital; Beijing Tiantan Hospital; Xuanwu Hospital... and other collaborators

Unknown

Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in China

Anti-NMDA Receptor Enphalitis
Beijing Tongren Hospital
Peking Union Medical College Hospital; Beijing Tiantan Hospital; Xuanwu Hospital... and other collaborators

Unknown

Multicenter and Prospective Clinical Registry Study of Autoimmune Encephalitis in China

Autoimmune Encephlitis in China
DynPort Vaccine Company LLC, A GDIT Company

Withdrawn

Safety, Tolerability and Immunogenicity of the Venezuelan Equine Encephalitis (VEE) Attenuated Live-Virus Vaccine

Venezuelan Equine Encephalitis

United States
Novartis
Novartis Vaccines

Completed

Study to Evaluate the Efficacy, Safety and Immunogenicity of Influenza Vaccine in Healthy Subjects (Aged 6 to <72 Months) Versus Control Vaccines

Influenza, Human

Finland, Italy, Germany
Ichor Medical Systems Incorporated
US Army Medical Research Institute of Infectious Diseases

Completed

Study of a DNA-based Venezuelan Equine Encephalitis Virus DNA Vaccine Administered by Electroporation in Healthy Volunteers

Venezuelan Equine Encephalitis Virus Infection

United States
Luminex Corporation

Completed

A Two Arm, Multi-Site Clinical Evaluation of the ARIES HSV 1&2 Assay in Symptomatic Patients

Herpes

United States
Pfizer

Completed

Safety Study of FSME-IMMUN NEW in Healthy Children and Adolescents Aged 1 to 15 Years

Tick-borne Encephalitis

Austria, Germany, Poland
Pfizer

Completed

TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)

Encephalitis, Tick-Borne

Poland
Pfizer

Completed

Safety Study in Volunteers From 16 to 65 Years of Age: FSME IMMUN NEW vs. ENCEPUR

Encephalitis, Tick-borne

Poland
Pfizer

Completed

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

Encephalitis, Tick-Borne

Germany, Austria, Poland
Pfizer

Completed

FSME IMMUN NEW Follow-up to Study 205 in Children Aged 6 to 16 Years

Encephalitis, Tick-borne

Germany
Pfizer

Completed

Immunogenicity and Safety Study of a Third Vaccination With FSME-IMMUN 0.5 mL in Subjects Previously Vaccinated According to a Rapid Immunization Schedule (Follow-up to Study 225)

Encephalitis, Tick-borne

Belgium
Pfizer

Completed

Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children

Encephalitis, Tick-borne

Austria
Pfizer

Completed

Immunogenicity and Safety Study of a Rapid Immunization Schedule With FSME-IMMUN 0.5 mL in Healthy Adults Aged 16 - 65 Years

Encephalitis, Tick-borne

Belgium
Pfizer

Completed

Investigation of the Seropersistence of TBE Antibodies and the Booster Response to FSME-IMMUN 0.5 ml in Adults Aged 18 - 67 Years

Tick-borne Encephalitis

Poland
Pfizer

Completed

FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years

Encephalitis, Tick-borne

Austria, Germany
Pfizer

Completed

Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years

Encephalitis, Tick-borne

Austria
Pfizer

Completed

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 1 to 6 Years.

Tick-borne Encephalitis

Austria, Germany
Pfizer

Completed

Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.

Tick-borne Encephalitis

Germany
Pfizer

Completed

FSME IMMUN NEW Follow-up to Study 208 in Volunteers Aged 16 to 66 Years

Encephalitis, Tick-borne

Poland
Jia Wei Wang,MD

Unknown

Multicenter and Prospective Clinical Registry Study of Anti-N-methyl-D-aspartate Receptor Encephalitis in Beijing Area (MuPRaNE)

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

China
New York Presbyterian Brooklyn Methodist Hospital

Withdrawn

Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.) (HELP)

Hepatic Encephalopathy | Cirrhosis | Altered Mental Status | HE | AMS

United States
Inviragen Inc.

Completed

Safety and Immunogenicity Study of an Inactivated Vaccine Against Hand, Foot and Mouth Disease Caused by Enterovirus 71

Hand, Foot and Mouth Disease

Singapore
Sanofi Pasteur, a Sanofi Company

Completed

Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines

Japanese Encephalitis | Hepatitis A

Thailand, Philippines
CONRAD
United States Agency for International Development (USAID); Follow-on African...

Completed

Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection

HIV Prevention

South Africa
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults (WinVax004)

West Nile Fever

United States
Valneva Austria GmbH

Completed

Safety Surveillance After Immunization With IXIARO

Japanese Encephalitis

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults

Dengue Fever | Dengue Hemorrhagic Fever | Dengue Virus | Dengue Diseases

Mexico
Medical University of Vienna

Completed

6-year Antibody Check After Third Vaccination Against Japanese Encephalitis

Post Other Specified Vaccination Encephalitis

Austria
KEMRI-Wellcome Trust Collaborative Research Program
London School of Hygiene and Tropical Medicine; University of Oxford; University...

Completed

Amoxicillin Versus Benzyl Penicillin for Treatment of Children Hospitalised With Severe Pneumonia

Pneumonia

Kenya

Search clinical trials for: HSV encephalitis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations